World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
26304
World Ranking
1668
National Ranking
59

Stephen J. Kent publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stephen J. Kent sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 449 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stephen J. Kent D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen J. Kent sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 79 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stephen J. Kent is affiliated with the University of Melbourne in Australia. Their research primarily focuses on medicine with a particular emphasis on immunology and microbiology.

The main fields of study covered by their publications include:

  • Medicine
  • Immunology and Microbiology

Their work also spans several subfields such as:

  • Infectious Diseases
  • Immunology
  • Epidemiology
  • Molecular Biology
  • Radiology, Nuclear Medicine and Imaging

Key topics investigated in their research include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • Influenza Virus Research Studies
  • T-cell and B-cell Immunology
  • Monoclonal and Polyclonal Antibodies Research

Frequent publication venues for this scientist consist of:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical & Translational Immunology
  • Frontiers in Immunology
  • Nature Communications
  • Immunology and Cell Biology

Stephen J. Kent has collaborated extensively with coauthors including:

  • Adam K. Wheatley
  • Jennifer A. Juno
  • Hyon-Xhi Tan
  • Amy W. Chung
  • Katherine Kedzierska

Recent papers from this scientist include:

  • Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection, 2021, Nature Medicine
  • Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection, 2022, Nature Immunology
  • Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies, 2020, Nature Microbiology
  • Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19, 2020, Nature Medicine
  • Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19, 2021, Nature Communications

Best Publications

  • Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.

    David S. Khoury;Deborah Cromer;Arnold Reynaldi;Timothy E. Schlub;Timothy E. Schlub

  • Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation

    Laura K. Mackay;Angus T. Stock;Joel Z. Ma;Claerwen M. Jones

  • Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.

    Wen Shi Lee;Adam K Wheatley;Stephen J Kent;Stephen J Kent;Brandon J DeKosky

  • Minimum information reporting in bio-nano experimental literature.

    Matthew Faria;Mattias Björnmalm;Kristofer J. Thurecht;Stephen J. Kent

  • Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus

    Stephen J. Kent;Anne Zhao;Susan J. Best;Jenalle D. Chandler

  • Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.

    Jennifer A. Juno;Hyon Xhi Tan;Wen Shi Lee;Arnold Reynaldi

  • Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.

    Marc Rigau;Marc Rigau;Simone Ostrouska;Thomas S Fulford;Darryl N Johnson

  • Tuberculous Meningitis: A 30-Year Review

    Kent Sj;Crowe Sm;Yung A;Lucas Cr

  • Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.

    Adam K Wheatley;Jennifer A Juno;Jing J Wang;Kevin J Selva

  • Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis.

    Deborah Cromer;Megan Steain;Arnold Reynaldi;Timothy E Schlub;Timothy E Schlub

  • Photometric Redshifts for the SDSS Early Data Release

    Istvan Csabai;Tamas Budavari;Andrew J. Connolly;Alexander S. Szalay

  • Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection

    Deborah Cromer;Jennifer A. Juno;David Khoury;Arnold Reynaldi

  • A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface

    Sandhya Bangaru;Shanshan Lang;Michael Schotsaert;Hillary A. Vanderven

  • Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing Antibodies

    Sinthujan Jegaskanda;Emma R. Job;Marit Kramski;Karen Laurie

  • From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.

    Emily H. Pilkington;Estelle J.A. Suys;Natalie L. Trevaskis;Adam K. Wheatley

  • Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity.

    Marios Koutsakos;Adam K. Wheatley;Liyen Loh;E. Bridie Clemens

  • Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery

    Katelyn T. Gause;Adam K. Wheatley;Jiwei Cui;Yan Yan

  • Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans.

    Henry J. Sutton;Racheal Aye;Racheal Aye;Azza H. Idris;Rachel Vistein

  • Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques

    Sinthujan Jegaskanda;Jason T. Weinfurter;Thomas C. Friedrich;Stephen J. Kent

  • Rapid Viral Escape at an Immunodominant Simian-Human Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitope Exacts a Dramatic Fitness Cost

    Caroline S Fernandez;Ivan Stratov;Robert De Rose;Katrina Walsh

  • Medicinal chemistry applied to a synthetic protein: Development of highly potent HIV entry inhibitors

    Oliver Hartley;Hubert François Gaertner;Jill Wilken;Darren Thompson

  • Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection

    Chansavath Phetsouphanh;David Darley;Anette Howe;C. Mee Ling Munier

Frequent Co-Authors

Adam K. Wheatley
Adam K. Wheatley University of Melbourne
Miles P. Davenport
Miles P. Davenport University of New South Wales
Anthony D. Kelleher
Anthony D. Kelleher University of New South Wales
P. Mark Hogarth
P. Mark Hogarth Burnet Institute
Sharon R. Lewin
Sharon R. Lewin University of Melbourne
Damian F. J. Purcell
Damian F. J. Purcell University of Melbourne
Ian A. Ramshaw
Ian A. Ramshaw University of Canberra
Katherine Kedzierska
Katherine Kedzierska University of Melbourne
David A. Cooper
David A. Cooper University of New South Wales
Thomas P. Davis
Thomas P. Davis University of Queensland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to diverse careers in healthcare, research, and biotechnology. For those interested in nursing pathways, there are several accelerated and flexible online options to consider. For instance, exploring an accelerated FNP program can fast-track your education toward becoming a Family Nurse Practitioner.

If you are an existing nurse looking to specialize further, understanding how to transition from FNP to ACNP can be a valuable step in advancing your clinical expertise and career opportunities. This transition often requires additional certifications but can significantly enhance your ability to work in acute care settings with complex patients.

For those coming from non-nursing backgrounds, several online nursing programs for non nurses offer pathways into the nursing profession without traditional prerequisites. These programs provide foundational knowledge and clinical training to start your journey in healthcare.

Additionally, if you’re looking for an entry point, the easiest ABSN programs to get into provide accessible options to earn a Bachelor of Science in Nursing quickly, helping you begin your nursing career sooner while complementing your immunology background.

Best Scientists Citing Stephen J. Kent

Trending Scientists